ELIZABETH BARNETT

H.R. 7142/S. 3832, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; S. 2973, The Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, The Lower Costs, More Transparency Act

Monitor S. 1339, Pharmacy Benefit Manager Reform Act; Monitor issues related to 340b; Expiring healthcare extenders

Issues pertaining to CHANGE cyber attack; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Telehealth extension; Issues related to Medicare provider directories; Issues related to Medicare Advantage marketing practices, prior authorization; S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, Lower Costs, More Transparency Act; Issues related to 2025 Medicare Part D Bid Information and Announces Premium Stabilization Demonstration; Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Issues related to the use of AI and it's correlation to prior authorization and utilization management policies

Issues related to CHANGE cyber attack; Issues related to healthcare transparency and consolidation; S. 1339, The Pharmacy Benefit Manager Reform Act; Issues related to cybersecurity, artificial intelligence, and healthcare data privacy; Expiring healthcare extenders

Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Issues related to Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Congressional briefing on SNP Supplemental Benefits; Expiring healthcare extenders

Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices and provider directories; Issues related to 2024 Medicare Advantage star ratings; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Issues related to Medcare Advantage prior authorization; Expiring healthcare extenders

LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA)

SAGE THERAPEUTICS, INC.

HEALTHCARE LEADERSHIP COUNCIL

UNITEDHEALTH GROUP INC

GENENTECH USA, INC.

SCAN HEALTH PLAN

HELP AT HOME

GRAIL, INC.

INCYTE CORPORATION

EDWARDS LIFESCIENCES LLC

KIDNEY CARE PARTNERS

PEDIATRIX MEDICAL GROUP, INC.